These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 17269833
1. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. Chan J, Hui RL, Spence MM. J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833 [Abstract] [Full Text] [Related]
2. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Cochrane Database Syst Rev; 2010 May 12; (5):CD005535. PubMed ID: 20464739 [Abstract] [Full Text] [Related]
3. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study. Vogelmeier C, Naya I, Ekelund J. Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479 [Abstract] [Full Text] [Related]
4. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Cochrane Database Syst Rev; 2015 Nov 24; 2015(11):CD007949. PubMed ID: 26594816 [Abstract] [Full Text] [Related]
5. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea TE, Hagiwara M, Stanford RH, Stempel DA. Clin Ther; 2008 Mar 24; 30(3):560-71. PubMed ID: 18405796 [Abstract] [Full Text] [Related]
6. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. Allen-Ramey FC, Bukstein D, Luskin A, Sajjan SG, Markson LE. J Manag Care Pharm; 2006 May 24; 12(4):310-21. PubMed ID: 16792437 [Abstract] [Full Text] [Related]
7. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Nannini LJ, Lasserson TJ, Poole P. Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD006829. PubMed ID: 22972099 [Abstract] [Full Text] [Related]
8. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Ni Chroinin M, Lasserson TJ, Greenstone I, Ducharme FM. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD007949. PubMed ID: 19588447 [Abstract] [Full Text] [Related]
9. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C, Wu EQ, Ray S, Colice GL. Clin Ther; 2009 Dec 08; 31(12):2779-803. PubMed ID: 20110019 [Abstract] [Full Text] [Related]
10. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Stempel DA, Riedel AA, Carranza Rosenzweig JR. Curr Med Res Opin; 2006 Mar 08; 22(3):463-70. PubMed ID: 16574030 [Abstract] [Full Text] [Related]
11. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Cochrane Database Syst Rev; 2010 Apr 14; (4):CD005533. PubMed ID: 20393943 [Abstract] [Full Text] [Related]
12. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM, Culler SD, Ershoff D, Gutierrez B. Clin Ther; 2009 Nov 14; 31(11):2574-83. PubMed ID: 20110003 [Abstract] [Full Text] [Related]
13. Prescription patterns in asthma patients initiating salmeterol in UK general practice: a retrospective cohort study using the General Practice Research Database (GPRD). DiSantostefano RL, Davis KJ. Drug Saf; 2011 Jun 01; 34(6):511-20. PubMed ID: 21585223 [Abstract] [Full Text] [Related]
14. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany. Aballéa S, Cure S, Vogelmeier C, Wirén A. Int J Clin Pract; 2008 Dec 01; 62(12):1870-9. PubMed ID: 18803555 [Abstract] [Full Text] [Related]
16. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Blais L, Beauchesne MF, Forget A. Respir Med; 2009 Feb 01; 103(2):237-43. PubMed ID: 18930647 [Abstract] [Full Text] [Related]
17. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM. Curr Med Res Opin; 2009 Jan 01; 25(1):1-13. PubMed ID: 19210134 [Abstract] [Full Text] [Related]
18. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews. Cates CJ, Wieland LS, Oleszczuk M, Kew KM. Cochrane Database Syst Rev; 2014 Feb 06; 2014(2):CD010314. PubMed ID: 24504983 [Abstract] [Full Text] [Related]
19. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination. Angus R, Reagon R, Cheesbrough A. Int J Clin Pract; 2005 Feb 06; 59(2):156-62. PubMed ID: 15854190 [Abstract] [Full Text] [Related]
20. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. Stempel DA, O'Donnell JC, Meyer JW. J Allergy Clin Immunol; 2002 Mar 06; 109(3):433-9. PubMed ID: 11897987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]